Cargando…
The effect of normalization of sodium on bone turnover markers in patients with epilepsy. A randomized single-blinded placebo-controlled trial
Hyponatremia [p[Na]<136 mmol/L] is an independent risk factor for decreased bone mineral density (BMD). However, whether hyponatremia represents a surrogate marker, or a direct causal relationship to bone loss remains unknown. The aim of the study was to investigate the effect of salt replacement...
Autores principales: | Diemar, Sarah Seberg, Jørgensen, Niklas Rye, Eiken, Pia, Suetta, Charlotte, Andersen, Noémi Becser, Sejling, Anne-Sophie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298402/ https://www.ncbi.nlm.nih.gov/pubmed/32566796 http://dx.doi.org/10.1016/j.conctc.2020.100587 |
Ejemplares similares
-
Associations between inflammatory markers, body composition, and physical function: the Copenhagen Sarcopenia Study
por: Kamper, Rikke S., et al.
Publicado: (2021) -
Amantadine for COVID-19 treatment (ACT study): a randomized, double-blinded, placebo-controlled clinical trial
por: Weis, Nina, et al.
Publicado: (2023) -
The association between normal serum sodium levels and bone turnover in patients with type 2 diabetes
por: Huang, Hai-yan, et al.
Publicado: (2022) -
Vitamin K supplementation and arterial calcification in dialysis: results of the double-blind, randomized, placebo-controlled RenaKvit trial
por: Levy-Schousboe, Karin, et al.
Publicado: (2021) -
Corrigendum: The association between normal serum sodium levels and bone turnover in patients with type 2 diabetes
por: Huang, Hai-yan, et al.
Publicado: (2022)